Seeing Is Believing
Currently out of the existing stock ratings of Robbie Marcus, 125 are a BUY (63.45%), 57 are a HOLD (28.93%), 15 are a SELL (7.61%).
Analyst Robbie Marcus works at JPMORGAN with a stock forecast success ratio of 62.59% fulfilled within 134.26 days on average.
Robbie Marcus’s has documented 398 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 24-Apr-2024.
Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
0.74
$0.52 (236.36%)
1
8 months 23 days ago
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
1.5
$1.28 (581.82%)
1 years 8 months 15 days ago
1/2 (50%)
$0.05 (3.45%)
2
Buy
1.5
$1.28 (581.82%)
1 years 10 months 7 days ago
1/5 (20%)
$0.96 (177.78%)
27
Sell
19
2 years 5 months 19 days ago
0/2 (0%)
$3.71 (16.84%)
Hold
23
$21.36 (1302.44%)
30
3 years 1 months 12 days ago
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus is most bullish on?
Which stock is Robbie Marcus is most reserved on?
What Year was the first public recommendation made by Robbie Marcus?